oxazoles has been researched along with al 8810 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burk, RM; Donde, Y; Krauss, AH; Landsverk, K; Liang, Y; Nieves, AL; Protzman, CE; Struble, C; Wang, JW; Woodward, DF | 1 |
| Harvey, BS; Nicotra, LL; Smid, SD; Vu, M | 1 |
2 other study(ies) available for oxazoles and al 8810
| Article | Year |
|---|---|
Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cats; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; In Vitro Techniques; Iris; Oxazoles; Receptors, Prostaglandin; Recombinant Proteins | 2007 |
Prostaglandin ethanolamides attenuate damage in a human explant colitis model.
Topics: Adult; Amides; Arachidonic Acids; Bimatoprost; Cloprostenol; Colitis; Colon, Sigmoid; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Endocannabinoids; Female; Humans; Immunohistochemistry; Interleukin-1beta; Male; Middle Aged; Oxazoles; Polyunsaturated Alkamides; Receptors, Prostaglandin; Sulfonamides; Tissue Culture Techniques; Tumor Necrosis Factor-alpha; Young Adult | 2013 |